Focus Taiwan
Date: 2017/10/02
By: Han Tin-tin and Isabel Wang
Taipei, Oct. 2 (CNA) The flu vaccine of Taiwan-based vaccine maker ADImmune
Image taken from Pixabay
Corporation (國光生技) is now available to people around Taiwan after the company obtained the approval of the country’s health authorities, the company said Monday.
The vaccine for domestic use is now being distributed nationwide after receiving the green light from the Ministry of Health and Welfare.
At the same time, ADImmune’s vaccine for China is now being shipped to its provinces and cities after the vaccine was approved by the China Food and Drug Administration in late September, according to the company.
In the United States, vaccines for four strains of the flu ADImmune developed in collaboration with U.S.-based drug maker Protein Sciences Corp. have been approved by the U.S. FDA and will soon be available in that market, the company said. [FULL STORY]
